Delta Financial Advisors LLC Sells 79 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Delta Financial Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,704 shares of the healthcare conglomerate’s stock after selling 79 shares during the period. Delta Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,874,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in UNH. AMF Tjanstepension AB boosted its holdings in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC boosted its holdings in shares of UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the period. Wealth Group Ltd. boosted its holdings in shares of UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after buying an additional 68 shares during the period. Howard Capital Management Group LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at $341,000. Finally, GSG Advisors LLC raised its stake in UnitedHealth Group by 14.4% during the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock valued at $435,000 after purchasing an additional 94 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Up 1.9 %

Shares of NYSE:UNH opened at $470.49 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s 50-day moving average price is $518.22 and its two-hundred day moving average price is $559.08. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $432.99 billion, a P/E ratio of 30.35, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.79%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.